These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23842752)

  • 1. TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production.
    McNab FW; Ewbank J; Rajsbaum R; Stavropoulos E; Martirosyan A; Redford PS; Wu X; Graham CM; Saraiva M; Tsichlis P; Chaussabel D; Ley SC; O'Garra A
    J Immunol; 2013 Aug; 191(4):1732-43. PubMed ID: 23842752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages.
    McNab FW; Ewbank J; Howes A; Moreira-Teixeira L; Martirosyan A; Ghilardi N; Saraiva M; O'Garra A
    J Immunol; 2014 Oct; 193(7):3600-12. PubMed ID: 25187652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production.
    Mielke LA; Elkins KL; Wei L; Starr R; Tsichlis PN; O'Shea JJ; Watford WT
    J Immunol; 2009 Dec; 183(12):7984-93. PubMed ID: 19933865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I IFN Inhibits Alternative Macrophage Activation during Mycobacterium tuberculosis Infection and Leads to Enhanced Protection in the Absence of IFN-γ Signaling.
    Moreira-Teixeira L; Sousa J; McNab FW; Torrado E; Cardoso F; Machado H; Castro F; Cardoso V; Gaifem J; Wu X; Appelberg R; Castro AG; O'Garra A; Saraiva M
    J Immunol; 2016 Dec; 197(12):4714-4726. PubMed ID: 27849167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPL-2 Inhibits IFN-β Expression via an ERK1/2-TCF-FOS Axis in TLR4-Stimulated Macrophages.
    Blair L; Pattison MJ; Chakravarty P; Papoutsopoulou S; Bakiri L; Wagner EF; Smale S; Ley SC
    J Immunol; 2022 Feb; 208(4):941-954. PubMed ID: 35082159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T Cell-Derived IL-10 Impairs Host Resistance to
    Moreira-Teixeira L; Redford PS; Stavropoulos E; Ghilardi N; Maynard CL; Weaver CT; Freitas do Rosário AP; Wu X; Langhorne J; O'Garra A
    J Immunol; 2017 Jul; 199(2):613-623. PubMed ID: 28584007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TPL-2 negatively regulates interferon-beta production in macrophages and myeloid dendritic cells.
    Kaiser F; Cook D; Papoutsopoulou S; Rajsbaum R; Wu X; Yang HT; Grant S; Ricciardi-Castagnoli P; Tsichlis PN; Ley SC; O'Garra A
    J Exp Med; 2009 Aug; 206(9):1863-71. PubMed ID: 19667062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Production of Type I IFN Determines the Reciprocal Levels of IL-10 and Proinflammatory Cytokines Produced by C57BL/6 and BALB/c Macrophages.
    Howes A; Taubert C; Blankley S; Spink N; Wu X; Graham CM; Zhao J; Saraiva M; Ricciardi-Castagnoli P; Bancroft GJ; O'Garra A
    J Immunol; 2016 Oct; 197(7):2838-53. PubMed ID: 27549173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions.
    Chowdhury FZ; Estrada LD; Murray S; Forman J; Farrar JD
    PLoS One; 2014; 9(3):e92187. PubMed ID: 24642963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells.
    Richardson ET; Shukla S; Sweet DR; Wearsch PA; Tsichlis PN; Boom WH; Harding CV
    Infect Immun; 2015 Jun; 83(6):2242-54. PubMed ID: 25776754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes.
    Ehlers S; Hölscher C; Scheu S; Tertilt C; Hehlgans T; Suwinski J; Endres R; Pfeffer K
    J Immunol; 2003 May; 170(10):5210-8. PubMed ID: 12734369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection.
    Travar M; Petkovic M; Verhaz A
    Arch Immunol Ther Exp (Warsz); 2016 Feb; 64(1):19-31. PubMed ID: 26362801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of cytokine and cytokine receptor mRNA expression upon infection of bone marrow-derived macrophages with Listeria monocytogenes.
    Demuth A; Goebel W; Beuscher HU; Kuhn M
    Infect Immun; 1996 Sep; 64(9):3475-83. PubMed ID: 8751887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages.
    Novikov A; Cardone M; Thompson R; Shenderov K; Kirschman KD; Mayer-Barber KD; Myers TG; Rabin RL; Trinchieri G; Sher A; Feng CG
    J Immunol; 2011 Sep; 187(5):2540-7. PubMed ID: 21784976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM14 Is a Key Regulator of the Type I IFN Response during
    Hoffpauir CT; Bell SL; West KO; Jing T; Wagner AR; Torres-Odio S; Cox JS; West AP; Li P; Patrick KL; Watson RO
    J Immunol; 2020 Jul; 205(1):153-167. PubMed ID: 32404352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I IFN Does Not Promote Susceptibility to Foodborne Listeria monocytogenes.
    Pitts MG; Myers-Morales T; D'Orazio SE
    J Immunol; 2016 Apr; 196(7):3109-16. PubMed ID: 26895837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subunit vaccine based on rH-NS induces protection against Mycobacterium tuberculosis infection by inducing the Th1 immune response and activating macrophages.
    Liu Y; Chen S; Pan B; Guan Z; Yang Z; Duan L; Cai H
    Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):909-922. PubMed ID: 27563010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate regulation of TPL-2 and NF-κB signaling in macrophages by NF-κB1 p105.
    Yang HT; Papoutsopoulou S; Belich M; Brender C; Janzen J; Gantke T; Handley M; Ley SC
    Mol Cell Biol; 2012 Sep; 32(17):3438-51. PubMed ID: 22733995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing suppressor of cytokine signaling-1 (SOCS1) in macrophages improves Mycobacterium tuberculosis control in an interferon-gamma (IFN-gamma)-dependent manner.
    Carow B; Ye Xq; Gavier-Widén D; Bhuju S; Oehlmann W; Singh M; Sköld M; Ignatowicz L; Yoshimura A; Wigzell H; Rottenberg ME
    J Biol Chem; 2011 Jul; 286(30):26873-87. PubMed ID: 21622562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis.
    Stanley SA; Johndrow JE; Manzanillo P; Cox JS
    J Immunol; 2007 Mar; 178(5):3143-52. PubMed ID: 17312162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.